Evidence-Based Management of MS Spasticity With Nabiximols Oromucosal Spray in Clinical Practice
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurodegenerative Disease Management
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap
Neurodegener Dis Manag 2022 Apr 04;[EPub Ahead of Print], A Chan, CV SilvánFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.